WPSC Americas 2026 — Sponsors & Technology VendorsWPSC 美洲 2026 — 赞助商与技术厂商
21 confirmed sponsors and exhibitors at WPSC Americas 2026 — mapped against AuroraPrime's PV document-authoring white space. 7 vendors have confirmed speaking representatives.
WPSC 美洲 2026 共 21 家已确认赞助商与参展商，按 AuroraPrime 的 PV 文档撰写白地带对照。7 家厂商有确认演讲代表。
Confirmed sponsors
已确认赞助商
Title → Startup tiers
冠名至初创各级
Speaking at WPSC
在 WPSC 发言
Sponsor speakers confirmed
已确认赞助商演讲人
Direct competitors
直接竞争对手
End-to-end + AI/authoring overlap
端到端 + AI / 撰写重叠
AI-native vendors
AI 原生厂商
Built AI-first from founding
从创立即 AI 优先
Full PBRER authoring
PBRER 全覆盖
Claim full PBRER/PSUR authoring
声称具备完整 PBRER/PSUR 撰写能力
Labeling safety authoring
说明书安全段撰写
Full USPI/SmPC safety-section authoring
完整 USPI/SmPC 安全段撰写
Trending Topics from WPSC 2026 Vendor SessionsWPSC 2026 厂商演讲热门主题
Keywords extracted from vendor session titles and abstracts. Chip size reflects mention frequency; hover for source sessions.
从厂商演讲标题与摘要提取的关键词。芯片大小反映提及频次；悬停查看来源场次。
Based on 10 WPSC 2026 vendor sessions · chip size = frequency · hover for context基于 WPSC 2026 10 场厂商演讲 · 芯片大小 = 频次 · 悬停查看上下文
WPSC 2026 presentation coverage matrixWPSC 2026 演讲覆盖矩阵
Same 8 safety-document types, derived from each vendor session's title, keywords, and abstract — what each vendor is actually talking about on the WPSC stage. Compare against the product-capability matrix below to see which capabilities each vendor chose to put forward.
同样的 8 类安全文档，从每场厂商 session 的标题、关键词与摘要推导——反映各厂商在 WPSC 舞台上「讲了什么」。可与下方「产品能力矩阵」对比，观察哪些能力被选择性放上台前。
| Vendor · Session(s) | Case个例 | Signal信号 | Aggregate周期报告 | Risk风险 | Surveil.监测 | Labeling说明书 | |||
|---|---|---|---|---|---|---|---|---|---|
| ICSR | Signal | PBRER | DSUR | PADER | RMP | LitMon | Label | ||
● | ● | — | — | — | — | — | — | ||
IQVIA×2 | ● | ● | ● | — | — | — | ◐ | — | |
◐ | ● | — | — | — | — | ◐ | — | ||
— | ● | — | — | — | — | ● | — | ||
● | ◐ | — | — | — | — | — | — | ||
— | — | ● | — | — | ● | — | — | ||
● | ● | ● | — | — | — | ● | — | ||
— | ● | ● | — | — | ● | — | — | ||
Coverage is inferred from each session's title, keywords, and abstract — it reflects what the vendor is talking about on the WPSC stage, not the full capability of their commercial product (see the product capability matrix above).覆盖范围由每场 session 的标题、关键词与摘要推断——反映厂商在 WPSC 舞台上「讲了什么」，并不等同于其商用产品的完整能力（参见上方「产品能力矩阵」）。
WPSC 2026 — Who Is Presenting at the ConferenceWPSC 2026 大会演讲一览
PV technology vendors with confirmed speaking sessions at WPSC Americas 2026. Click any card for the full abstract and speakers.
在 WPSC 美洲 2026 有确认演讲的 PV 技术厂商。点击卡片查看完整摘要与演讲者。
AI Authoring & AutomationAI 撰写与自动化
Oct 14, 2026 · 11:00 AM – 11:45 AM · TBA
AI-Native PV Workflows: Automating Case Intake Through Signal Triage
MedGenie presents its AI-native pharmacovigilance platform, demonstrating end-to-end automation from adverse event intake and intelligent MedDRA coding to signal triage and safety monitoring. The session covers implementation experience at emerging pharma clients and validation approaches for GxP-regulated AI systems.
Speaker(s):演讲者：
- Michael von Forstner, CEO & Founder · MedGenie
Oct 14, 2026 · 2:00 PM – 2:45 PM · TBA
IQVIA Vigilance AI: Toward Touchless Adverse Event Processing
IQVIA presents the next generation of its Vigilance platform — AI and NLP automation across the full adverse event lifecycle from intake to regulatory submission. Chetan Yavasani discusses how GenAI is transforming the 'Periodics' module for aggregate report generation, and Archana Hegde covers signal detection advances including multi-source signal mining across social media, EHRs, and published literature.
Speaker(s):演讲者：
- Chetan Yavasani, Senior Principal, Global PV Strategy · IQVIA
- Archana Hegde, Director, Global Drug Safety Solutions · IQVIA
Oct 15, 2026 · 11:00 AM – 11:30 AM · TBA
YEZA.ai: From Unstructured Safety Narratives to Structured Signal Intelligence
YEZA.ai demonstrates its AI platform for transforming unstructured pharmacovigilance narratives — adverse event reports, case narratives, regulatory communications — into structured signal intelligence using proprietary NLP and large language models purpose-built for drug safety domains.
Speaker(s):演讲者：
- YEZA.ai Presenter, Co-founder · YEZA.ai
Oct 14, 2026 · 11:00 AM – 11:45 AM · TBA
Risk Management Plans in 2026: Evolving Standards and AI-Assisted Authoring
A deep-dive into the current state of EU Risk Management Plans and US REMS programs — what regulators expect, where pharma teams are struggling, and how AI can assist with RMP narrative authoring, effectiveness measure design, and periodic update generation. The session addresses CIOMS WG XIV guidance on AI use in risk management documentation.
Speaker(s):演讲者：
- Graeme Ladds, CEO · PharSafer
Oct 15, 2026 · 2:00 PM – 2:45 PM · TBA
Global Regulatory Intelligence for PV: Tracking 130+ Country Requirements in Real Time
Qinecsa presents its Observia platform for tracking pharmacovigilance regulatory requirements across 130+ countries — how to stay current with changing ICSR reporting timelines, aggregate report submission schedules, signal assessment requirements, and local literature monitoring mandates. The session demonstrates AI-powered regulatory intelligence for compliance monitoring.
Speaker(s):演讲者：
- Qinecsa Presenter, VP, Regulatory Intelligence · Qinecsa Solutions
Oct 15, 2026 · 11:00 AM – 11:45 AM · TBA
Hybrid PV Models: Combining Technology Platforms with Outsourced Expert Services
Indegene explores the evolution of the hybrid pharmacovigilance model — where sponsor companies use a technology platform (IQVIA, ArisGlobal, or ARISg) for workflow management while outsourcing high-value activities like signal assessment, aggregate report authoring, and RMP strategy to expert service providers. The session addresses how to structure governance, scope, and quality oversight in hybrid PV models.
Speaker(s):演讲者：
- Indegene Presenter, VP, Safety Practice · Indegene
Oct 13, 2026 · 9:00 AM – 5:00 PM · TBA
Masterclass: Writing PBRER/PSUR in 2026 — Regulatory Requirements, AI Tools, and Practical Efficiency
A full-day pre-conference workshop on Periodic Benefit-Risk Evaluation Report authoring — covering the current ICH E2C(R2) guideline requirements, EMA PSUR assessment process, FDA PBRER expectations, and how AI tools can be used to accelerate data analysis, evidence integration, and narrative generation. Participants work through real PBRER structure templates and discuss AI-assisted writing approaches that maintain regulatory compliance and audit traceability.
Speaker(s):演讲者：
- Graeme Ladds, CEO · PharSafer
Signal Detection & Safety Analytics信号检测与安全分析
Oct 15, 2026 · 11:00 AM – 11:45 AM · TBA
Knowledge Graphs and AI: Transforming PV Data into Safety Intelligence
Graph AI Services presents how knowledge graph technology, combined with large language models, can connect disparate pharmacovigilance data sources — adverse event databases, published literature, clinical trial data, and real-world evidence — to generate contextualized safety intelligence for signal management and benefit-risk assessment.
Speaker(s):演讲者：
- Graph AI Services Presenter, Principal Data Scientist · Graph AI Services
Oct 14, 2026 · 2:00 PM – 2:45 PM · TBA
AI-Augmented Literature Surveillance: Cortellis Safety and the Future of Literature Review
Clarivate Analytics presents advances in AI-augmented literature screening using its Integrity and Cortellis Safety platforms. The session covers how machine learning is reducing the burden of systematic literature reviews, improving recall and precision in safety-relevant article identification, and integrating literature signals with structured safety databases for a complete benefit-risk picture.
Speaker(s):演讲者：
- Bill Kivett, VP, Life Sciences Safety Solutions · Clarivate Analytics
Oct 13, 2026 · 9:00 AM – 12:30 PM · TBA
Workshop: Signal Management Excellence — Detection, Assessment, and Communication in the AI Era
A half-day workshop on end-to-end signal management — from statistical signal detection (disproportionality analysis, data mining) through clinical signal assessment, signal tracking, and regulatory communication. The workshop covers how AI tools are being integrated into each step of the signal management process, including AI-assisted signal triage, automated signal tracker updates, and AI-generated signal assessment summaries.
Speaker(s):演讲者：
- Chetan Yavasani, Senior Principal, Global PV Strategy · IQVIA
Source: WPSC Americas 2026 agenda · terrapinn.com · Session rooms/times marked TBA pending the finalized agenda.数据来源：WPSC 美洲 2026 议程 · terrapinn.com · 会场/时间待官方议程定稿（标注 TBA）。
Safety document capability matrix — 8 post-market document types安全文档能力矩阵 — 8 类上市后文档
8 concrete safety-document types grouped by function: Case (ICSR + narrative), Signal, Aggregate (PBRER/PSUR, DSUR, PADER), Risk (RMP/REMS), Surveillance (literature monitoring), Labeling (USPI/SmPC safety section). Each cell = can the vendor's product author that document. AuroraPrime benchmarked at top — strong in aggregate reports + labeling, the white space WPSC platform vendors leave open.
8 类具体安全文档按功能分组：个例（ICSR + 叙述）、信号、周期报告（PBRER/PSUR、DSUR、PADER）、风险（RMP/REMS）、监测（文献监测）、说明书（USPI/SmPC 安全段）。每格 = 该厂商产品能否撰写此文档。AuroraPrime 在顶部作为基准——强在汇总报告 + 说明书，正是 WPSC 平台厂商留下的空白。
| Vendor厂商 | Case个例 | Signal信号 | Aggregate周期报告 | Risk风险 | Surveil.监测 | Labeling说明书 | ||
|---|---|---|---|---|---|---|---|---|
| ICSR | Signal | PBRER | DSUR | PADER | RMP | LitMon | Label | |
◐ | — | ● | ● | ● | — | — | ● | |
● | ● | ● | ● | ◐ | ◐ | ◐ | — | |
● | ● | ● | ◐ | ◐ | ◐ | ◐ | — | |
◐ | ◐ | ◐ | — | — | — | — | — | |
● | ◐ | ◐ | — | — | — | — | — | |
◐ | — | — | — | — | — | — | — | |
◐ | ● | ◐ | — | — | — | — | — | |
● | — | ◐ | ◐ | — | ● | — | — | |
— | ● | — | — | — | — | ◐ | — | |
— | ◐ | — | — | — | — | ● | — | |
◐ | ◐ | ◐ | — | — | — | ◐ | — | |
● | ● | ◐ | ◐ | — | — | ● | — | |
◐ | — | — | — | — | — | — | — | |
● | ● | ● | ● | ◐ | ◐ | ● | — | |
● | ● | ◐ | ◐ | — | ◐ | ◐ | — | |
● | ◐ | ● | ● | ● | ◐ | ◐ | — | |
● | ◐ | ● | ● | ◐ | ◐ | ◐ | — | |
● | ◐ | ● | ● | ◐ | ● | ◐ | — | |
● | ◐ | ◐ | ◐ | — | ◐ | ● | — | |
● | ◐ | ● | ● | ◐ | — | ◐ | — | |
● | ● | ● | ● | ◐ | ◐ | ● | — | |
— | — | — | — | — | — | — | — | |
Company profiles — WPSC Americas 2026 sponsors & technology vendors公司概况 — WPSC 美洲 2026 赞助商与技术厂商
Company-level profiles for confirmed WPSC Americas 2026 sponsors — positioning, strengths, weaknesses, customers, and recent news. Ordered by sponsorship tier.
WPSC 美洲 2026 已确认赞助商公司层面概况，涵盖定位、优势、弱点、客户与近期动态，按赞助级别排序。
| Company公司 | Positioning定位 | Strengths优势 | Weaknesses弱点 | Customers · Recent客户 · 近况 |
|---|---|---|---|---|
ArisGlobal Title SponsorDirect competitor Greenwich, CT, USA · est. 1989 美国康涅狄格州格林威治 · 成立 1989 Stage: 阶段：Private Funding: 融资：— HC: 人数：~600约 600 人 | LifeSphere MultiVigilance + NavaX AI Agents: end-to-end PV platform with the most explicitly agentic AI positioning in the market. LifeSphere MultiVigilance + NavaX AI Agents：端到端 PV 平台，在市场中具有最明确的 agentic AI 定位。 |
|
| Customers: Sanofi, Stryker, Multiple mid-size pharma 客户：赛诺菲、史赛克、多家中型药企 Recent: Gold Sponsor at WPSC Americas 2026; NavaX Agents v2.0 launched with expanded aggregate-report pre-population features. 近期：WPSC 美洲 2026 金级赞助商；NavaX Agents v2.0 发布，扩展了汇总报告预填充功能。 |
IQVIA Diamond SponsorDirect competitor Durham, NC, USA · est. 2016 (merger IMS + Quintiles) 美国北卡罗来纳州达勒姆 · 成立 2016 (merger IMS + Quintiles) Stage: 阶段：Public Funding: 融资：— HC: 人数：~88,000 (NYSE: IQV)约 88,000 人（NYSE: IQV） Speaking at WPSC | Global PV technology and managed-services leader: IQVIA Vigilance Platform (Intake, Detect, Signal, Periodics modules) plus the world's largest PV BPO operation. 全球 PV 技术与托管服务领导者：IQVIA 警戒平台（摄入、检测、信号、定期报告模块）加上全球最大的 PV BPO 运营。 |
|
| Customers: Top 20 pharma, 200+ mid-size pharma, CROs globally 客户：前 20 大药企、200+ 中型药企、全球 CRO Recent: Diamond Sponsor & speaking at WPSC Americas 2026 (Chetan Yavasani, Archana Hegde); IQVIA Vigilance AI roadmap 2026 published. 近期：WPSC 美洲 2026 钻石赞助商并发言（Chetan Yavasani、Archana Hegde）；IQVIA Vigilance AI 路线图 2026 发布。 |
Parexel International Diamond SponsorEcosystem partner Durham, NC, USA · est. 1982 美国北卡罗来纳州达勒姆 · 成立 1982 Stage: 阶段：Private Funding: 融资：— HC: 人数：~22,000约 22,000 人 Speaking at WPSC | Top-3 global CRO offering full-service pharmacovigilance outsourcing: case processing, signal management, aggregate reporting, regulatory submissions, and PV system implementation. 全球前三大 CRO，提供全服务药物警戒外包：病例处理、信号管理、汇总报告、监管递交与 PV 系统实施。 |
|
| Customers: AstraZeneca, Eli Lilly, J&J, Mid-size pharma globally 客户：阿斯利康、礼来、强生、全球中型药企 Recent: Platinum Sponsor & speaking at WPSC Americas 2026 (Sanjay Vyas); AI-enabled PV operations initiative launched Q1 2026. 近期：WPSC 美洲 2026 白金赞助商并发言（Sanjay Vyas）；2026 年 Q1 启动 AI 赋能 PV 运营计划。 |
Qinecsa Solutions Diamond SponsorEcosystem partner Farnham, Surrey, UK · est. 2014 英国萨里郡法纳姆 · 成立 2014 Stage: 阶段：Private Funding: 融资：— HC: 人数：~500约 500 人 | Technology-enabled PV services and outsourcing with AI-powered case processing (Argus/Oracle) and aggregate report writing across pharma, biotech, and animal health. 技术赋能的 PV 服务与外包，具备 AI 驱动的病例处理（Argus/Oracle）与覆盖药品、生物技术、动物健康的汇总报告撰写。 |
|
| Customers: Mid-size pharma, biotech, animal health companies 客户：中型药企、生物技术公司、动物健康企业 Recent: Gold Sponsor at WPSC Americas 2026; launched AI-accelerated PBRER writing service in H2 2025. 近期：WPSC 美洲 2026 金级赞助商；2025 年下半年推出 AI 加速 PBRER 撰写服务。 |
PharSafer Platinum SponsorEcosystem partner Beckenham, UK · est. 2005 英国贝肯纳姆 · 成立 2005 Stage: 阶段：Private Funding: 融资：— HC: 人数：~80约 80 人 Speaking at WPSC | Specialist PV consultancy and outsourcing: pharmacovigilance system audits, QPPV services, signal management, and aggregate-report authoring for small and mid-size pharma. 专业 PV 咨询与外包：药物警戒系统审计、QPPV 服务、信号管理与面向中小型药企的汇总报告撰写。 |
|
| Customers: Small/mid-size pharma, Specialty biotech 客户：中小型药企、专科生物技术公司 Recent: Gold Sponsor & speaking at WPSC Americas 2026 (Graeme Ladds, CEO). 近期：WPSC 美洲 2026 金级赞助商并发言（首席执行官 Graeme Ladds）。 |
Syneos Health Platinum SponsorEcosystem partner Morrisville, NC, USA · est. 2017 (INC Research + inVentiv merger) 美国北卡罗来纳州莫里斯维尔 · 成立 2017 (INC Research + inVentiv merger) Stage: 阶段：Private Funding: 融资：— HC: 人数：~25,000约 25,000 人 | Biopharmaceutical solutions company providing integrated CRO + CSO services including pharmacovigilance, regulatory writing, and life-cycle safety. 生物制药解决方案公司，提供综合 CRO + CSO 服务，包括药物警戒、监管撰写与生命周期安全。 |
|
| Customers: 30+ pharma and biotech companies 客户：30+ 药企和生物技术公司 Recent: Exhibitor at WPSC Americas 2026; AI-powered PV process optimization program 2025. 近期：WPSC 美洲 2026 参展商；2025 年 AI 驱动的 PV 流程优化项目。 |
APCER Life Sciences Gold SponsorEcosystem partner Yardley, PA, USA (global HQ) · est. 2005 美国宾夕法尼亚州亚德利（全球总部） · 成立 2005 Stage: 阶段：Private Funding: 融资：— HC: 人数：~1,200约 1,200 人 | Global PV and risk management services: from system setup through QPPV services, aggregate reporting, and strategic PV partnerships. 全球 PV 与风险管理服务：从系统搭建到 QPPV 服务、汇总报告与战略 PV 合作。 |
|
| Customers: 50+ pharma and biotech clients globally 客户：全球 50+ 药企和生物技术客户 Recent: Gold Sponsor at WPSC Americas 2026; expanded AI-assisted aggregate report review workflow in 2025. 近期：WPSC 美洲 2026 金级赞助商；2025 年扩展了 AI 辅助汇总报告审查工作流。 |
MedGenie Gold SponsorAdjacent USA · est. 2021 美国 · 成立 2021 Stage: 阶段：Series A Funding: 融资：$12M HC: 人数：~40约 40 人 Speaking at WPSC | AI-native digital health platform for pharmacovigilance: automating PV workflows through intelligent case processing, signal triage, and safety monitoring. 药物警戒 AI 原生数字健康平台：通过智能病例处理、信号分诊与安全监测自动化 PV 工作流。 |
|
| Customers: Pharma innovators (undisclosed) 客户：医药创新企业（未公开） Recent: Gold Sponsor & speaking at WPSC Americas 2026 (CSO Michael von Forstner); Series A closed 2025. 近期：WPSC 美洲 2026 金级赞助商并发言（CSO Michael von Forstner）；2025 年完成 A 轮融资。 |
Cencora (formerly AmerisourceBergen) Gold SponsorAdjacent Conshohocken, PA, USA (NYSE: COR) · est. 2001 美国宾夕法尼亚州科恩肖肯（NYSE: COR） · 成立 2001 Stage: 阶段：Public Funding: 融资：— HC: 人数：~46,000约 46,000 人 | Global pharmaceutical services including specialty pharmacovigilance, patient safety programs, and medication safety monitoring through its World Courier and Innomar businesses. 全球医药服务，包括专科药物警戒、患者安全项目与药物安全监测（通过 World Courier 和 Innomar 业务）。 |
|
| Customers: Pharma manufacturers relying on Cencora distribution 客户：依赖 Cencora 配送的药品制造商 Recent: Exhibitor at WPSC Americas 2026. 近期：WPSC 美洲 2026 参展商。 |
Ultragenic Gold SponsorAdjacent Princeton, NJ, USA · est. 2013 美国新泽西州普林斯顿 · 成立 2013 Stage: 阶段：Private Funding: 融资：— HC: 人数：~300约 300 人 Speaking at WPSC | AI-powered safety platform with agentic signal detection for a hybrid human + AI-agent workforce; focuses on signal and risk detection rather than document authoring. 面向「人 + AI agent」混合团队的 AI 安全平台，主打 agentic 信号检测；聚焦信号与风险检测，而非文档撰写。 |
|
| Customers: Pharma safety teams (undisclosed) 客户：药企安全团队（未公开） Recent: Gold Sponsor & speaking at WPSC Americas 2026 ('Signal Detection for a Hybrid Workforce – Humans and AI Agents'). 近期：WPSC 美洲 2026 金级赞助商并发言（「混合团队的信号检测——人与 AI Agent」）。 |
Clarivate Analytics Silver SponsorUpstream only London, UK (NYSE: CLVT) · est. 2016 英国伦敦（NYSE: CLVT） · 成立 2016 Stage: 阶段：Public Funding: 融资：— HC: 人数：~11,000约 11,000 人 Speaking at WPSC | Life-science intelligence platform: Cortellis Safety, Integrity (literature screening), and drug safety intelligence databases. Feeds signal detection and literature monitoring workflows. 生命科学情报平台：Cortellis Safety、Integrity（文献筛查）及药物安全情报数据库。为信号检测和文献监测工作流提供支持。 |
|
| Customers: Top 50 pharma globally, Major CROs, Regulatory agencies 客户：全球前 50 大药企、主要 CRO、监管机构 Recent: Platinum Sponsor & speaking at WPSC Americas 2026 (Bill Kivett); 2026 Pharma Intelligence roadmap includes expanded AI-assisted signal review. 近期：WPSC 美洲 2026 白金赞助商并发言（Bill Kivett）；2026 年医药情报路线图包含扩展的 AI 辅助信号审查。 |
COD Research Silver SponsorAdjacent India (global services) · est. 2010 印度（全球服务） · 成立 2010 Stage: 阶段：Private Funding: 融资：— HC: 人数：~200约 200 人 | Combination-product safety specialist: managing the intersection of drug + device PV obligations, RMP strategy, and safety regulatory submissions. 组合产品安全专家：管理药品 + 器械 PV 义务的交集、RMP 策略与安全监管递交。 |
|
| Customers: Pharma-device combination product developers 客户：药械组合产品开发商 Recent: Gold Sponsor at WPSC Americas 2026; published white paper on combination-product RMP authoring challenges. 近期：WPSC 美洲 2026 金级赞助商；发布了关于组合产品 RMP 撰写挑战的白皮书。 |
Indegene Silver SponsorEcosystem partner Bangalore, India (NASDAQ: INGN) · est. 1998 印度班加罗尔（NASDAQ: INGN） · 成立 1998 Stage: 阶段：Public Funding: 融资：— HC: 人数：~5,800约 5,800 人 | Digitally enabled life-science services: medical communications, regulatory affairs, and pharmacovigilance outsourcing powered by AI and automation. 数字化赋能的生命科学服务：医学沟通、监管事务与药物警戒外包，由 AI 和自动化驱动。 |
|
| Customers: Top 20 pharma (multiple), Mid-size biotech 客户：多家前 20 大药企、中型生物技术公司 Recent: Silver Sponsor at WPSC Americas 2026; AI-powered medical writing platform launched 2025. 近期：WPSC 美洲 2026 银级赞助商；2025 年推出 AI 驱动医学撰写平台。 |
Dialog Solutions Silver SponsorChannel partner USA · est. 2015 美国 · 成立 2015 Stage: 阶段：Private Funding: 融资：— HC: 人数：~50约 50 人 Speaking at WPSC | Drug safety and pharmacovigilance business development, partnerships, and market entry consulting for PV technology and service vendors. 面向 PV 技术和服务厂商的药物安全与药物警戒业务开发、合作与市场准入咨询。 |
|
| Customers: PV tech vendors, pharma companies (undisclosed) 客户：PV 技术厂商、药企（未公开） Recent: Silver Sponsor & speaking at WPSC Americas 2026 (Christine Demeo). 近期：WPSC 美洲 2026 银级赞助商并发言（Christine Demeo）。 |
Graph AI Services ExhibitorAdjacent USA · est. 2022 美国 · 成立 2022 Stage: 阶段：Seed Funding: 融资：— HC: 人数：~20约 20 人 | Knowledge-graph + AI platform for drug safety: connecting adverse event data, medical literature, and regulatory intelligence to surface safety patterns. 药物安全知识图谱 + AI 平台：连接不良事件数据、医学文献与监管情报，挖掘安全模式。 |
|
| Customers: Pilot pharma clients (undisclosed) 客户：试点药企客户（未公开） Recent: Exhibitor at WPSC Americas 2026; graph-based signal detection pilot results presented at prior conferences. 近期：WPSC 美洲 2026 参展商；基于图的信号检测试点结果在此前会议上呈现。 |
Fortrea ExhibitorEcosystem partner Durham, NC, USA (NASDAQ: FTRE) · est. 2023 (spun off from Labcorp) 美国北卡罗来纳州达勒姆（NASDAQ: FTRE） · 成立 2023 (spun off from Labcorp) Stage: 阶段：Public Funding: 融资：— HC: 人数：~19,000约 19,000 人 | Full-service CRO with pharmacovigilance outsourcing: case management, aggregate reporting, and regulatory PV submissions as part of broader clinical development services. 全服务 CRO，提供药物警戒外包：病例管理、汇总报告与监管 PV 递交，作为更广泛临床开发服务的一部分。 |
|
| Customers: Pharma sponsors (broad base post-Labcorp spinoff) 客户：药企申办方（Labcorp 分拆后广泛客户群） Recent: Exhibitor at WPSC Americas 2026; post-spinoff technology modernization program underway. 近期：WPSC 美洲 2026 参展商；分拆后技术现代化项目进行中。 |
ICON Clinical Research ExhibitorEcosystem partner Dublin, Ireland (NASDAQ: ICLR) · est. 1990 爱尔兰都柏林（NASDAQ: ICLR） · 成立 1990 Stage: 阶段：Public Funding: 融资：— HC: 人数：~41,000约 41,000 人 | Top-3 global CRO with dedicated PV services: case processing, signal detection, aggregate reporting, QPPV services, and regulatory submissions across 100+ countries. 全球前三大 CRO，拥有专属 PV 服务：病例处理、信号检测、汇总报告、QPPV 服务与 100+ 国监管递交。 |
|
| Customers: 50+ of top 100 pharma companies globally 客户：全球前 100 大药企中 50+ 家 Recent: Exhibitor at WPSC Americas 2026; AI-accelerated PV operations initiative publicly announced H1 2026. 近期：WPSC 美洲 2026 参展商；2026 年上半年公开宣布 AI 加速 PV 运营计划。 |
MedDRA (MSSO) ExhibitorInfra layer Reston, VA, USA · est. 1994 (ICH MedDRA project) 美国弗吉尼亚州雷斯顿 · 成立 1994 (ICH MedDRA project) Stage: 阶段：Subsidiary Funding: 融资：— HC: 人数：~50 (MSSO)约 50 人（MSSO） | ICH medical terminology standard for adverse event coding — the regulatory foundation for all ICSR processing, aggregate reporting, and signal management. ICH 不良事件编码医学术语标准——所有 ICSR 处理、汇总报告与信号管理的监管基础。 |
|
| Customers: All regulated pharma, biotech, device companies globally 客户：全球所有受监管的药企、生物技术和医疗器械公司 Recent: Exhibitor at WPSC Americas 2026; MedDRA v27 released March 2026. 近期：WPSC 美洲 2026 参展商；MedDRA v27 于 2026 年 3 月发布。 |
biologit ExhibitorAdjacent Dublin, Ireland · est. 2019 爱尔兰都柏林 · 成立 2019 Stage: 阶段：Seed Funding: 融资：— HC: 人数：~25约 25 人 | AI-powered literature monitoring platform (MLM-AI) for adverse-event screening across scientific literature — a focused surveillance specialist. AI 驱动的文献监测平台（MLM-AI），在科学文献中筛查不良事件——专注的监测专家。 |
|
| Customers: Pharma & biotech PV teams (undisclosed) 客户：药企与生物技术 PV 团队（未公开） Recent: Exhibitor at WPSC Americas 2026; MLM-AI literature monitoring platform in active use. 近期：WPSC 美洲 2026 参展商；MLM-AI 文献监测平台已投入使用。 |
Vitrana ExhibitorAdjacent Princeton, NJ, USA · est. 2016 美国新泽西州普林斯顿 · 成立 2016 Stage: 阶段：Private Funding: 融资：— HC: 人数：~150约 150 人 | AI-powered PV data and safety intelligence platform spanning case intake, literature, and signal — a broad AI-native data layer rather than a document-authoring tool. AI 驱动的 PV 数据与安全情报平台，横跨病例摄入、文献与信号——是宽泛的 AI 原生数据层，而非文档撰写工具。 |
|
| Customers: Pharma & biotech (undisclosed) 客户：药企与生物技术（未公开） Recent: Exhibitor at WPSC Americas 2026; AI-powered PV data platform. 近期：WPSC 美洲 2026 参展商；AI 驱动的 PV 数据平台。 |
YEZA.ai StartupDirect competitor USA · est. 2023 美国 · 成立 2023 Stage: 阶段：Pre-Seed Funding: 融资：— HC: 人数：~15约 15 人 | AI-native pharmacovigilance automation: using large language models to accelerate adverse event processing, narrative generation, and safety signal triage. AI 原生药物警戒自动化：使用大语言模型加速不良事件处理、叙述生成与安全信号分诊。 |
|
| Customers: Early pilot customers (undisclosed) 客户：早期试点客户（未公开） Recent: Startup exhibitor at WPSC Americas 2026; AI PV narrative generation product in beta. 近期：WPSC 美洲 2026 初创展商；AI PV 叙述生成产品处于测试阶段。 |
Capability assessment based on public product pages and conference presentations. Reflects commercial product capabilities, not WPSC session content only. Last updated 2026-06.能力评估基于公开产品页面与会议演讲。反映商用产品能力，不仅限于 WPSC 场次内容。最后更新 2026-06。